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Abstract: The aim of this study was to explore the impact of mental illness among patients 
with migraine. We performed MedLine and PsycINFO searches from 1980 to 2008. Research 
has systematically documented a strong bidirectional association between migraine and psy-
chiatric disorders. The relationship between migraine and psychopathology has often been 
clinically discussed rather than systematically studied. Future research should include sound 
methodologically-based studies focusing on the interplay of factors behind the relationship 
between migraine, suicide risk, and mental illness.
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Introduction
The World Health Organization (WHO) has placed migraine 19th among all causes 
of disability worldwide (12th in women) according to metric years of healthy life 
lost to disability.1 In the US and Europe, migraine is the cause of an estimated 
250,000,000 lost days from work or school every year. In a study of 1,660 people in 
Belgium, the lifetime prevalence of migraine was 20.2% (95% confidence intervals 
[CI]: 18.3%–22.2%), significantly higher for women than for men, with the high-
est prevalence in the age group 35–44 years. On average, 10.6 lost working days 
due to migraine were reported per absentee and per year, on average 2.3 days for 
migraine sufferers, and 0.4 days for all employees. Migraine is estimated to account 
for about 1,154,336 lost working days each year in Flanders and Brussels. However, 
underreporting of symptoms, attacks, and sick leave days was estimated at about 
50%, depending on the time frame. Sixty-nine percent of the migraine sufferers use 
medication regularly.2 Clearly, the importance of headache disorders, particularly 
the primary forms, is established by their distribution worldwide, their duration (the 
majority being lifelong conditions), and their imposition of both disability and lifestyle 
restrictions on large numbers of people. For all these reasons, headache disorders 
should be a public health priority.3
Chronic daily headache (CDH), a group of disorders in which headache occurs 15 
or more days per month for at least three months,4,5 such as chronic migraine (CM), 
chronic tension-type headache (CTTH), hemicrania continua, new daily persistent 
headache, and medication overuse headache (MOH), is often comorbid with other 
conditions,4,5 such as depression (in up to 80% of migraine sufferers), anxiety (70%),6 
sleep complaints, slight (age/gender-adjusted odds ratio [OR] = 2.4 [1.7–3.2]), moderate 
(OR = 3.6 [2.6–5.0]), and severe (OR = 7.5 [4.21–3.4]),7 and fibromyalgia (35%).8Neuropsychiatric Disease and Treatment 2010:6 82
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Headache is one of the most common neurologic 
symptoms, and it often results in presentation in the emer-
gency department (ED).9–12 In an Italian nationwide epidemi-
ologic survey, headache was second only to cerebrovascular 
disorders (28% versus 22%) among the most common neu-
rologic causes for attendance at an ED.13 In a prospective 
study, diagnoses of ED patients reporting headache indicated 
primary headache disorders in the majority as opposed to 
secondary headaches attributed to underlying pathologies.14 
Migraine (22% of diagnoses) was the most frequent primary 
headache and twice as common as tension-type headache 
(TTH, 11%), although 18% of cases were unspecified primary 
headache. Of the secondary headaches, 13% were serious or 
life-threatening conditions, including subarachnoid hemor-
rhage, cerebrovascular disease, and meningitis.15
Similar results have been found in pediatric ED atten-
dance, 1% of which were attributed by an Italian survey to 
headache.16 Primary headache was again diagnosed in most 
cases (57%). However, over 90% of secondary headaches 
were caused by viral illnesses, but only 4% of children were 
in any immediate medical danger.16
Patients suffering from different types of headache 
typically complain of numerous accompanying symptoms 
(behavioral and somatic), which may be partially related 
to psychiatric comorbidity.17 Somatic symptoms have been 
demonstrated to be more common in patients with CM,18 
especially for severe headaches with accompanying depres-
sion or anxiety. CM, moreover, should be considered as dis-
tinct from migraine with aura (MA), migraine without aura 
(MwoA), and migraine aura without headache (without 
a history of characteristic migraine headaches). Endicott 
reported that a high percentage of patients with major 
affective disorders had episodes with transient neurologic 
symptoms resembling the aura symptoms that can be seen 
in migraine patients.19
The diagnosis of headache does not always follow stan-
dard criteria and is complicated by the emergence of new 
terms and criteria, while the diagnosis of psychiatric disorders 
is based on a multiaxial coding system, ie, the DSM-IV .20 
Axis I includes diagnoses of clinical disorders and other 
conditions that may be a focus of clinical attention, whereas 
Axis II includes diagnoses of personality disorders and 
mental retardation. Some Axis I and II psychiatric disorders 
are associated with headache. The prevalence and impact of 
these psychiatric disorders among headache patients have 
been the focus of several studies that have analyzed the 
relationship between migraine (and other types of headache) 
and major depression, anxiety, illicit drug abuse, nicotine 
dependence, and suicide attempts.21 Unfortunately, as noted 
by Silberstein et al,22 the relationship between headache and 
psychopathology has often been discussed only clinically 
rather than systematically studied. However, this relation-
ship represents an important area for future headache 
research. Thus, the aim of the present study was to explore 
the prevalence and impact of mental illness among patients 
with migraine.
Methods
We performed careful MedLine and PsycINFO searches from 
1980 to 2008. The following search terms were used: “head-
ache” OR “migraine” and related terms, AND “psychiatric 
disorder”, “psychiatric comorbidity”, “substance abuse”, 
“outcome”, “suicid”* (which comprises suicide, suicidal, 
suicidality, and other suicide-related terms). In addition, 
each category was cross-referenced with the others using 
the MeSH method. We will review the historical context, 
pathophysiologic basis, epidemiology, risk factors, migraine, 
and the association with comorbid psychiatric disorders and 
substance abuse (include substance dependence/abuse in this 
section), suicide risk, and prognosis.
Historical context
Epidemiologic research has systematically documented a 
strong association between primary headaches and psy-
chiatric disorders.23 Living described the occurrence of 
depressed mood, irritability, anxiety, memory, and atten-
tion deficit in patients with chronic headache in 1895.24 In 
1937, Wolf systematically studied these associations in 
patients with migraine who were not taking treatment for 
psychiatric illness.25 He defined the “migraine personal-
ity” as a mixture of “personality features and reactions 
dominant in individuals with migraine” including “feel-
ings of insecurity with tension manifested as inflexibility, 
conscientiousness, meticulousness, perfectionism, and 
resentment”.26 This particular personality, characterized 
by anxious and depressive traits, is frequently found in 
subjects with CM.27
In 1989, Endicott found that migraine was common 
among patients with major affective disorders and occurred 
with highest frequency in those with characteristics similar to 
DSM-IV bipolar patients.19 Wang et al studied the comorbid-
ity between headache and depression in the elderly, which 
had rarely been the focus of research in the past.28 They 
were able to demonstrate that the risk of current depression 
was much greater in migraine sufferers than in nonmigraine 
patients.28Neuropsychiatric Disease and Treatment 2010:6 83
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More recently, several studies have portrayed this 
relationship as bidirectional.23 Migraine sufferers have a more 
than threefold risk of developing depression compared with 
nonmigraine patients, while depressed patients who have 
never suffered from migraine in the past have a more than 
threefold risk of developing migraine compared with non-
depressed patients. The relationship is also specific because 
the presence of migraine or severe nonmigraine headache 
increases a patient’s risk of developing depression or panic 
attack disorder, whereas the presence of depression or panic 
attack disorder is associated with a greater risk of developing 
migraine, but not severe nonmigraine headache.29
In 2008, Hung et al found that mental stress and depressive 
symptoms (anhedonia, decreased concentration, decreased 
libido, decreased energy, and sleep disorders) were the most 
common precipitating or aggravating factors for headache in 
patients with major depressive disorders.30 They suggested 
that headache was not a symptom of depression, but that 
headache and several mood and anxiety disorders are clinical 
entities that share some pathophysiologic bases.
Pathophysiologic bases
The importance of genetic factors in migraine31,32 and in mood 
disorders,33–35 raises the hypothesis of a mechanism common 
to both conditions,29,31 with the suggestion that similar neuro-
chemical abnormalities might be implicated.36 Recent studies 
of psychopathology and headache have demonstrated shared 
neuropathic mechanisms between migraine and affective 
disorders,37 involving limbic activation.38 Recent neurosci-
ence research and experimental techniques such as positron 
emission tomography and functional magnetic resonance 
have shown that pain and mental suffering, such as depres-
sion, are related to the same brain regions (anterior cingulate, 
amygdala, orbitofrontal cortex, and temporal lobe).39 These 
data indicate that, even at the biologic level, pain and mental 
suffering share a common basis. Cady et al have suggested 
cosensitization of the sensory and affective components 
of head pain as a possible phenomenon.40 This hypothesis 
focuses on neuroplastic processes in corticolimbic structures, 
activated by both nociceptors and psychologic stimuli over a 
period of time, resulting in an integrated relationship between 
migraine (or pain) and psychiatric disorders in susceptible 
individuals. This susceptibility may be caused by a familial 
genetic variant of serotonergic dysfunction, alterations in 
monoamine systems, or channelopathy (a defect in calcium 
channels).32 Subsequent clinical development of these two 
pathologies, starting from a familial genetic variant of sero-
tonergic dysfunction, initially involving pain regulation and 
cerebral perfusion with primarily onset of migraine, and 
then mood regulation, increases the risk for mood disorder 
onset.21,41–43
Studying the relationship between subtypes of migraine 
headaches and affective disorders may be a way to explore 
further a possible common pathomechanism in both disor-
ders.44 Disturbances in serotonergic systems are found in 
completed and attempted suicides,45 and the serotonergic 
systems are involved in the pathophysiology of both migraine 
and affective disorders.46,47
Epidemiology
Epidemiologic and clinical research consistently documents 
an association between depressive, bipolar, and anxiety dis-
orders with migraine.48–50 Epidemiologic data have indicated 
a clinical association between migraine and mood disorders, 
with a lifetime prevalence of major depression three times 
higher among patients with migraine compared with patients 
without migraine.51 Affective disorders occur with at least 
a threefold greater frequency among recurrent headache 
patients than among the general population, and the preva-
lence increases in clinical populations, especially those with 
CDH.48,52 In the case of CDH, a comorbid psychiatric disorder 
was present in 90% in a sample of 88 clinical patients.6
This comorbidity between CDH and psychiatric disorders 
seems to be more frequent in a particular type of patient. 
Taking into consideration different variables, it is possible 
to characterize a likely migraine person.
Gender
Women are significantly more likely to be affected than 
men. Women are four times more likely to develop migraine 
and two times more likely to develop major depression48 
and, compared with men, often receive a diagnosis of both 
migraine (24% versus 9%) and major depression (24% versus 
13%) by age 30, with the relative female risk increasing for 
migraine in late adolescence and for major depression after 
about age 20. In an epidemiologic study in Denmark, the gen-
der distribution for both migraine aura without headache and 
MA was 1:2.53 However, another study reported that migraine 
aura without headache may be more common in men.54
Age of onset
MA is strongly associated with an early age of onset (OR: 
11.4, age 15 years, OR: 5.6, age 15–24 years), and this 
variable explains the difference between the two migraine 
groups (migraine aura versus migraine aura without head-
ache) better than the variables of suicide attempt (OR: 3.2, Neuropsychiatric Disease and Treatment 2010:6 84
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P = 0.13, NS) or affective temperament (OR: 4.0, P = 0.047).44 
Migraine onset was earlier than mood disorder onset, and 
Franchini et al found no difference in migraine distribution 
according to the polarity of mood disorder,41 consistent with 
the findings of a previous study.51
Family factors
Mood disorder and migraine in first-degree relatives are 
significantly related to the risk of comorbidity.41
Psychiatric disorders
Endicott found that migraine was common among patients 
with major affective disorders and occurred with highest 
frequency in those with bipolar disorder II (51% preva-
lence of migraine in patients with characteristics similar 
to bipolar II patients).19 In a questionnaire study of bipolar 
patients, Mahmood et al found that 26% fulfilled the criteria 
for a diagnosis of migraine.55
Migraine subtype
A higher prevalence of psychiatric comorbidity was 
observed in chronic forms of headache versus episodic 
forms, especially in CM patients. A high prevalence of 
sleep disorders, bowel disturbances, and fatigue frequently 
occurs in patients with chronic pain disorders, especially 
fibromyalgia.56 For episodic headaches, comorbid psy-
chiatric disorders are more prevalent in migraine than 
in TTH.56
Migraine in children and adolescents
Headache is common among children and adolescents. About 
10%–30% of children and adolescents report weekly or daily 
headaches.57 Migraine occurs in 3%–15% of children,58,59 
while 9%–33% of patients suffer from nonmigraine headache 
at least monthly.60
Risk factors
Many risk factors are independently involved in the devel-
opment of psychiatric comorbidity in migraine patients 
and those with CDH, among them genetic factors, higher 
depression scores, female gender, and chronic depression.61 
Moreover, previous studies have reported a positive relation-
ship between the frequency of headaches and the level of 
depression in headache patients (mood disorders were more 
frequent in patients who had chronic headache for more than 
five years).62 A report of two cases showed that a reduction 
in the severity of depression was associated with a reduction 
in headache severity.63
Both CM and CTTH share a surprisingly similar 
personality profile in women (along with an increased level 
of muscle tenderness) in association with psychiatric comor-
bidity, suggesting the involvement of these factors in the 
chronicity of headaches.64,65 An association between headache 
and certain personality traits or psychiatric disorders has also 
been reported in adults.31,66 In children, specific traits, such 
as rigidity and emotional inhibition, have been found among 
children with primary headache.67,68 TTH children were also 
more likely than migraine patients to have the temperament 
traits of shyness and irritability.69
Psychiatric comorbidity is associated not only with higher 
vulnerability to headache, but also with developing drug 
resistance and chronicity of primary headache.70
Several behavioral and psychologic risk factors are 
associated with the progression of headache from episodic 
to chronic and daily.71,72 And psychologic distress may play 
an even greater role in the transformation and chronicity of 
headache than does analgesic overuse/abuse.
A French study done in 2006 compared 30 simple 
migraineurs (SM) with 32 transformed migraineurs (TM) 
with medication overuse for impairment, emotional adjust-
ment, and coping strategies.73 TM with medication overuse 
is a complication of migraine characterized by an increase 
of crisis frequency and by a parallel increase of medication 
intake. Prevalence of TM with analgesic overuse in France 
seems to be as high as 3% in the general population.74
Lafittau et al reported that TM is associated with an 
increased disability concerning housework, leisure, work, 
and social activities.73 Statistical analysis shows higher 
(P  0.001) Hospital Anxiety and Depression (HAD) scores 
for emotional distress (mean score = 32.2 ± 10.9) in TM 
than in SM (24.1 ± 7.3). TM were characterized by differ-
ent coping strategies against pain, for example, the use of 
  “dramatization”, “distraction”, and “praying”, which are 
considered to be dysfunctional coping strategies, although 
SM used “reinterpretation”, which is associated with better 
adjustment in term of disability and emotional distress.75
Migraine and psychiatric disorders
Migraine and Hamilton Rating Scale scores
The Hamilton Rating Scale, the most used clinical scale for 
assessing depression, includes headache in two items, while 
the Hamilton Rating Scale for anxiety includes headache in 
one item. There is research claiming that depression affects 
the onset and chronicity of primary headache. The average 
scores on the Hamilton Rating Scale for anxiety and depres-
sion were higher in headache sufferers than in healthy people. Neuropsychiatric Disease and Treatment 2010:6 85
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The frequency of headache attacks, history of headaches, 
and gender (women more than men) were correlated with 
scores on the Hamilton Rating Scale for both anxiety and 
depression.76
Psychiatric disorders and headache
Psychiatric comorbidity was found more frequently in 
patients with chronic pain syndromes,77 and recent research 
shows a strong relationship between psychiatric disorders and 
headache, both CDH and TTH. This relationship is complex 
and multifaceted, with existing studies confirming high rates 
of comorbidity between psychiatric disorders (especially 
depression and anxiety) and migraine and TTH, implicating 
comorbid psychiatric disorders as risk factors for headache 
progression and chronicity, and underscoring the need for 
assessment and treatment of relevant disorders.78 Depression 
was the psychiatric disorder most frequently associated with 
headache.23
The presence of migraine or severe nonmigraine head-
ache increases a patient’s risk of developing depression or 
panic attack disorder, whereas the presence of depression 
or panic attack disorder is associated with a greater risk of 
developing migraine, but not severe non-migraine head-
ache.29 Merikangas et al in a prospective study,31 supported 
the hypothesis that anxiety induces or facilitates the onset 
of a primary headache, acting as a trigger for the subse-
quent development of a mood disorder such as depression. 
They assumed that migraine follows anxiety after several 
years, while it precedes the onset of depression by about 
four years.31
In a community-based study, high comorbidity with psy-
chiatric disorders and suicidal risk was found in adolescents 
with CDH. The presence of migraine attacks, especially MA, 
was the major predictor for these associations.79 Subjects 
with migraine, anxiety, and chronic depression also had poor 
health-related quality of life. Migraine, specific phobias, 
and panic disorder were important and independent comor-
bidities predicting poor health-related quality of life.30 These 
comorbidities have been identified in several epidemiologic 
studies,21,48,49,52 as well as in clinical studies of patients 
seeking treatment.52 The more common psychiatric condi-
tions related to migraine are depression, bipolar disorders, 
anxiety (in particular, generalized anxiety disorders31), and 
somatoform disorders. These psychiatric comorbidities are 
more specifically related to migraine than to TTH, both in 
children and in adults.31,80,81
In patients with episodic migraine, the presence of psy-
chiatric disorders, such as anxiety or depression or both, is 
characterized by elevated muscle tenderness in the head, 
and even more in the neck, facilitating the evolution of 
the headache into the chronic form.64 In cases of episodic 
migraine without other psychiatric comorbidities, headache 
can be considered to be a manifestation of a somatoform 
disorder (including somatization disorder, conversion dis-
order, hypochondriasis, or pain disorder associated with 
psychologic factors),20 similar to other somatic complaints 
such as fatigue, loss of appetite, gastrointestinal symptoms, 
and urinary complaints.
It is important to distinguish between migraine with or 
without aura and migraine aura without headache. As dem-
onstrated in one population-based epidemiologic study,31 
MA was associated with multiple anxiety disorders, recurrent 
brief depression, and hypomania, whereas only the phobic 
and panic disorders were more frequent among patients suf-
fering from MwoA. Patients with TTH did not differ from 
controls with respect to any of the affective or anxiety disor-
ders. Oedegaard et al showed that a large number of patients 
presenting with major affective disorders have migraine 
aura without headache. The patients who had migraine aura 
without headache had a low level of affective temperament 
and a low probability of having made a suicide attempt, as 
well as a higher age of onset of migraine auras as compared 
with patients suffering from MA.44
Verri et al found an association between CDH and at 
least one psychiatric disorder in 90% of their cases, mainly 
generalized anxiety disorders in 69.3% cases, followed by 
major depression in 25% and dysthymia in 17%.6 Verri 
in 1998 and later Juang in 2000, in two different studies, 
affirmed that a long-standing major depressive disorder and 
chronic depression were the most common comorbidities 
among these patients,6,82 especially when the chronic head-
ache syndrome had lasted for more than five years. However, 
Juang et al found that the frequency of any type of anxiety 
disorder was significantly higher in patients with CM than 
in those with CTTH.82
In previous studies, the comorbidity between TTH and 
psychiatric disorders has been investigated only in clinical 
populations in which it has been showed that this associa-
tion was more frequent in CTTH than in episodic TTH and 
that anxiety and mood disorders were higher in the CTTH 
patients than in controls,23,83 with significantly higher anxi-
ety and depression scores in CTTH patients compared with 
headache-free controls.84,85 Moreover, in previous studies, 
among patients with episodic TTH, especially in CTTH, 
affective disorders were found to be more frequent.86 Of the 
three studies conducted in clinical samples, none reported Neuropsychiatric Disease and Treatment 2010:6 86
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any significant differences between migraine and TTH in 
terms of psychiatric comorbidity.85,87,88
Personality disorders have been less frequently examined 
in empirical headache research than have affective disorders. 
Torelli et al found that subjects with TTH had significantly 
higher scores than healthy controls on measures of automatic 
thoughts and alexithymia, and lower scores on assertive-
ness.89 Patients with CTTH had higher automatic thought 
scores than patients with episodic TTH. In another small 
sample study, using the Minnesota Multiphasic Personality 
Inventory II version (MMPI-2) with CDH patients, signifi-
cantly high scores have been reported for the scales measur-
ing hysteria, hypochondriasis, psychasthenia, depression, and 
social introversion.90
TTH patients have higher scores for the traits of emo-
tionality and shyness, and lower for sociability, than patients 
with migraine.69 A higher emotionality score was also found 
among the parents and siblings of TTH children.69 High 
scores on emotionality and shyness can be considered to 
be symptoms of “behavioral inhibition”.91,92 School-aged 
children who present with this trait are often irritable, shy, 
fearful, and introverted, and this temperament trait seems to 
increase the vulnerability to depressive and multiple anxiety 
disorders.93,94 Patients with TTH may have, as a group, more 
behavioral, emotional and temperament difficulties than 
children referred for migraine.69
This conclusion seems to be at odds with an epidemio-
logic study in Finland which found that psychiatric symptoms 
tended to be more strongly associated with migraine than with 
TTH, without any difference in anxiety symptoms.95 How-
ever, personality disorders are considered to be a complica-
tion for headache management,96–98 and significant headaches 
are a complaint of about 60% of patients with personality 
disorders presenting for acute treatment at hospital EDs.99
Tables 1 and 2 show details of representative studies of 
the prevalence of migraine in bipolar disorder as well as of 
studies demonstrating an association between migraine and 
depression.
Suicide risk
We have already described the shared pathophysiology of 
migraine, depression, and suicide.21,42,43 Suicide attempts 
seem to be more frequent in patients suffering from migraine 
than in the general population, especially in females and in 
patients having MA.100 These risk factors for suicidal behav-
ior have also been found in the general population.21,31,81,96 In 
contrast, CDH subtypes, headache frequencies, or medication 
overuse are not correlated with suicidal behavior.79
Suicide attempts are associated with migraine,29 and MA 
also independently predicted a high suicidal risk (score 10 
on the MINI Suicidality Module) in adolescents with CDH.79 
Wang et al investigated the relationship between migraine and 
suicidal ideation in a nonreferred sample of 3,963 adolescents 
(2,040 male and 1,923 female; mean age 14.0 ± 0.9 years; 
93% of the target cohort).101 Suicidal ideation was reported 
in 8.5% of the sample. Compared with non-migraine sub-
jects, subjects with migraine displayed a higher frequency of 
suicidal ideation (16.1% versus 6.2%), especially those with 
MA (23.9%). Suicidal ideation was associated with higher 
headache frequency and headache-related disability but, 
after controlling for depression scores and sociodemographic 
characteristics, the association remained significant only for 
MA and high headache frequency. The relationship between 
MA and depression seems to be bidirectional.29
Hesdorffer et al found that the co-occurrence of major 
depression, suicide attempts, and MA increased the risk of 
unprovoked seizures more than the risk associated with either 
major depression or MA alone.102 The authors suggested 
that combinations of major depression, suicidality, MA, and 
seizure could constitute a cluster of conditions not hitherto 
described. In this model, it is possible, in their opinion, that 
the relationship between these conditions reflects a causal 
pathway where one brain dysfunction (eg, manifested by 
major depression) engenders other brain dysfunctions 
(eg, manifested by MA and unprovoked seizures).102
A history of MA, but not MwoA, is associated with 
increased frequency of suicidal ideation and suicide attempts 
in patients with major depression and with current or previous 
Table 1 Prevalence of migraine in bipolar disorder from 
representative studies100
Reference  Method  Sample 
size (n)
Migraine 
prevalence %
127 Medical section of 
DIGS
327 (F = 186) 21.1 (F = 26.5)
128 Self-report of 
  headache
100 49.0
55 Self-report of IHS 
migraine criteria
81 (F = 37) 25.9 (F = 27.0)
129 Diagnosis by 
neurologist
30 20.0
51 Administered IHS 
migraine criteria
27 Bipolar I 13.0 
Bipolar II 77.0
130 
 
Mother’s report of 
past diagnosis of 
migraine
21 
 
28.6 (F = 0, M = 21) 
 
Abbreviations: HIS, International Headache Society; DIGS, diagnostic interview 
for genetic studies.Neuropsychiatric Disease and Treatment 2010:6 87
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affective episodes.21,44,49,51,79 Oedegaard et al found that 17% 
of patients having migraine aura without headache (n = 18) 
had made a suicide attempt and had a lower frequency of 
the affective temperament as well as a higher age of onset of 
migraine aura compared with patients having MA (n = 57).44 
However, the frequency of suicidal thoughts was approxi-
mately equal in the two groups.44
In 116 consecutive adult outpatients with a diagnosis of 
CDH, De Filippis et al found that 28% had moderate to severe 
depression and 35% had severe hopelessness.103 Analyses also 
indicated that the quality of life, temperament, illness per-
ception, and psychologic turmoil were associated. However, 
after hierarchical multivariate regression analysis, only the 
MINI suicidal intent score was associated with quality of life. 
It seems then that suicide risk may play a central role in affect-
ing quality of life of patients with chronic headache.103
The pain associated with headache is itself a potential 
independent risk factor for suicide, particularly among 
those with chronic headache or multiple sources of coexist-
ing pain.104 Individuals suffering from chronic pain may be 
particularly appropriate for suicide screening and interven-
tion efforts. Innamorati et al proposed a new scale called the 
Italian Perceived Disability Scale,105 as a screening tool to 
identify comorbidity with emotional distress and disorders. 
This scale has proved able to predict suicidal intent and assess 
disability in patients with CDH.105
Substance dependence and abuse
The impact of headache on the person and society is a public 
health issue. Recently, a study evaluated 51% of headache 
prevalence in Europe, of which 14% of cases were migraine. 
About 4%–5% of the general population suffers from fre-
quent, almost daily, headache attacks, and therefore 4% of 
the adult population is affected by chronic forms of headache, 
which constitutes an even more relevant problem in terms of 
health and social policies.106
Population studies estimate that patients who have low-
  frequency episodic migraine or high-frequency episodic 
migraine will transition to CM at a rate of about 2.5% per 
year.107 Evers et al have reported that MOH was diagnosed in 
8% of headache patients referred to a neurologic clinic,108 while 
Aaseth reported that the prevalence of MOH was 3.7%.109
Psychiatric comorbidity is common in MOH patients and 
seems to play a role in the evolution of migraine to MOH.110 
Psychiatric comorbidity may be linked to medication overuse 
in patients suffering from migraine.111 Pakalnis et al found 
that headache patients had significantly more symptoms of 
anxiety, depression, and somatization compared with con-
trols.110 Patients with CDH were at higher risk for emotional 
disorders, and medication overuse was a significant occur-
rence. Mitsikostas and Thomas replicated this finding, but 
only when MOH involved CDH.85
Migraine is associated with substance abuse, nicotine 
dependence, and illicit drug use.112 Substance-related dis-
orders have been examined in only three cross-sectional 
studies. Breslau et al found an increased risk of alcohol and 
drug abuse in migraine sufferers,21 while Merikangas and 
the Epidemiologic Catchment Area Study did not, probably 
because substance abuse was highly comorbid with bipolar 
disorder in the Breslau study.21,31,113
In experimental studies, it has been shown that chronic 
use of analgesics may alter the functioning of the central 
5-HT system.114 A comorbid psychiatric disorder may cause 
a stronger need to take analgesics in headache patients.115,116 
Table 2 Selected studies presenting the association between 
migraine and depression100
Study 
 
Method 
 
Migraine and 
depression OR, 
95% CI
Bidirectional 
relationship 
OR, 95% CI
Longitudinal studies
48 IHS migraine 
criteria
Not assessed New-onset migraine 
3.5, 2.2–5.6 
New-onset depression 
3.6, 2.6–5.2
29 IHS migraine 
criteria
3.5, 2.6–4.6 New-onset migraine 
2.8, 2.2–3.5 
New-onset depression 
2.4, 1.8–3.0
131 
 
 
IHS migraine 
criteria 
 
Not assessed 
 
 
New-onset migraine 
3.4, 1.4–8.7 
New-onset depression 
5.8, 2.7–12.3
Cross-sectional studies
81 Diagnosis by 
neurologist
2.2, 1.1–4.8 Not assessed
29 IHS migraine 
criteria
3.5, 2.6–4.6 New-onset migraine 
2.8, 2.2–3.5 
New-onset depression 
2.4, 1.8–3.0
113 IHS migraine 
criteria
3.1, 2.0–4.4 New-onset migraine 
0.68, 0.02–2.0
132 IHS migraine 
criteria
2.7, 2.3–3.2 Not assessed
133 Diagnosis by 
neurologist
2.8, 2.2–3.7 Not assessed
134 
 
 
IHS migraine 
criteria 
 
Strict migraine 2.7, 
2.2–3.3 
Probable migraine 1.9, 
1.5–2.4
Not assessed 
 
 
Abbreviation: HIS, International Heachache Society.Neuropsychiatric Disease and Treatment 2010:6 88
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Depressive patients may have decreased pain thresholds or 
may feel more unpleasant pain, resulting in analgesic overuse 
for the relief of their headache. Anxiety focused on the pos-
sibility of increasing pain may also play a role.117
Prognosis
Psychiatric comorbidity complicates the management of 
patients with headache, and the prognosis for headache 
treatment is poor.23,118–121 An eight-year followup study of 
100 young adults with headache studied the relationship 
between psychiatric disorders at initial evaluation and 
headache status at followup.37 Patients with two or more 
psychiatric disorders at initial evaluation exhibited no 
improvement or deterioration in headache in 57% of the 
cases at followup; 29% of cases were improved and only 
14% cases were headache-free.37 In contrast, patients with 
no or only one psychiatric disorder exhibited greater head-
ache improvement eight years after the initial evaluation. 
Only 15% of cases were the same or worse, while 53% of 
cases were improved and 40% cases were headache-free.37 
Migraine and depression independently exert a significant 
negative influence on quality of life.122
The results of studies on predictors of the outcome of 
CDH are conflicting. Some authors have reported that the 
predictors of persistent headaches include the presence of 
major depression,79 while others have reported that depres-
sion did not predict the persistence of CDH.28 Depression 
is associated with increased personal suffering, mortality 
(suicide is the most common cause of death in patients 
with major depression), utilization of healthcare services, 
decreased functioning, and reduced quality of life.123–125 
Other studies report that levels of emotional functioning 
and perception of stress, independent of the level of pain at 
baseline, were predictive of frequency, intensity, and dura-
tion of headaches.83,126 In depressed patients, headache in 
itself is a stressful event, and headache attacks are triggered 
or exacerbated by stress and depressed mood, producing a 
vicious cycle that is difficult to break.
Conclusions
Migraine is one of the major causes of disability and lost 
working days worldwide.1 Our analysis of the literature 
indicates a strong association between primary headaches 
and psychiatric disorders.23 The evidence of a possible link 
between chronic headache and psychiatric disorder is not a 
recent finding. Back in 1895, Living described the occurrence 
of depressed mood, irritability, and anxiety in patients with 
chronic headache.24 However, recently, research indicates 
that this association may be explained by shared neuropathic 
mechanisms between pain and affective disorders,37 perhaps 
involving limbic activation.38 Moreover, the literature shows 
an association between suicide attempts and migraine,29 
and also indicates that MA may independently predict high 
suicidal risk in adolescent patients with CDH.79
Our recent studies are consistent with these results, and 
indicate that patients with a diagnosis of CDH and migraine 
have severe hopelessness,103 and perceived disability.105 This 
evidence suggests that psychologic assessment is necessary 
in patients with CM, and also that the presence of CM or 
headache has to be carefully monitored in patients with 
mental illness.
Selection of papers suitable for this study allowed inclu-
sion only of articles published in English peer-reviewed 
journals, or articles published in non-English journals with 
an abstract in English. Included were those studies that added 
an original contribution to the literature. Clearly, articles 
included in this selective review may be only part of the 
relevant existing literature.
In conclusion, we are in agreement with authors who rec-
ommend future research with sound methodology focusing 
on the interplay of factors behind the relationship between 
migraine, suicide risk, and mental illness.
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